These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26071831)

  • 41. [Late pacemaker lead thrombosis treated with rivaroxaban].
    Michałek P; Kubaszek-Kornatowska A; Pręgowska-Chwała B
    Kardiol Pol; 2014; 72(9):840. PubMed ID: 25231418
    [No Abstract]   [Full Text] [Related]  

  • 42. Chronic leg ulcerations associated with livedoid vasculopathy successfully treated with rivaroxaban.
    Miguel D; Elsner P; Goetze S
    Clin Exp Dermatol; 2020 Jan; 45(1):120-122. PubMed ID: 30767258
    [No Abstract]   [Full Text] [Related]  

  • 43. Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome.
    Daaboul Y; Korjian S; Plotnikov AN; Burton P; Braunwald E; Wiviott SD; Gibson CM
    J Am Coll Cardiol; 2018 Mar; 71(9):1048-1049. PubMed ID: 29495985
    [No Abstract]   [Full Text] [Related]  

  • 44. An Adolescent With Cerebral Thrombosis Successfully Treated With Rivaroxaban.
    Lin CM; Wang DS; Chen SJ
    Pediatr Emerg Care; 2022 Nov; 38(11):e1667. PubMed ID: 35947051
    [No Abstract]   [Full Text] [Related]  

  • 45. Questions about the reliability of ROCKET-AF anticoagulation data.
    Christopoulos C
    BMJ; 2016 Feb; 352():i1039. PubMed ID: 26908261
    [No Abstract]   [Full Text] [Related]  

  • 46. Effectiveness of rivaroxaban for thromboprophylaxis of prosthetic heart valves in a porcine heterotopic valve model.
    Greiten LE; McKellar SH; Rysavy J; Schaff HV
    Eur J Cardiothorac Surg; 2014 May; 45(5):914-9. PubMed ID: 24306948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?
    Ahmad T; Butler J
    Eur J Heart Fail; 2015 Jul; 17(7):647-51. PubMed ID: 26018996
    [No Abstract]   [Full Text] [Related]  

  • 48. When It Works.
    Ende J
    Am J Med; 2019 Nov; 132(11):e763-e764. PubMed ID: 30951680
    [No Abstract]   [Full Text] [Related]  

  • 49. Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.
    Hsia J; Szarek M; Anand S; Patel MR; Debus S; Berkowitz SD; Muehlhofer E; Haskell LP; Bauersachs RM; Bonaca MP
    J Am Coll Cardiol; 2021 Aug; 78(7):757-759. PubMed ID: 34384556
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanical valve thrombosis with dabigatran.
    Price J; Hynes M; Labinaz M; Ruel M; Boodhwani M
    J Am Coll Cardiol; 2012 Oct; 60(17):1710-1. PubMed ID: 23021328
    [No Abstract]   [Full Text] [Related]  

  • 51. Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial.
    Prins MH; Bamber L; Cano SJ; Wang MY; Erkens P; Bauersachs R; Lensing AW
    Thromb Res; 2015 Feb; 135(2):281-8. PubMed ID: 25483215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rivaroxaban in acute coronary syndromes--is it prime time?
    Asrar ul Haq M; van Gaal WJ
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):649-58. PubMed ID: 24746010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clear Instructions and Patient Education Key for Xarelto.
    Shastay A
    Home Healthc Now; 2020; 38(4):225-226. PubMed ID: 32618785
    [No Abstract]   [Full Text] [Related]  

  • 54. [Left ventricular thrombosis in acute myocardial infarction: incidence, complications, and clinical effects of calcium heparin].
    Ferraiuolo G; Mancini P; Vitucci NC; Palamara A
    Riv Eur Sci Med Farmacol; 1992; 14(2):87-9. PubMed ID: 1484989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Surgical treatment of renal cancer, complicated by the vena cava inferior and right atrium thrombosis].
    Belov IuV; Komarov RN
    Khirurgiia (Mosk); 2013; (1):65-9. PubMed ID: 23503354
    [No Abstract]   [Full Text] [Related]  

  • 56. [Thrombolysis of right atrial transit thrombus].
    Müller C; Axthelm EH
    Dtsch Med Wochenschr; 1992 Oct; 117(41):1578. PubMed ID: 1396152
    [No Abstract]   [Full Text] [Related]  

  • 57. The Voyager PAD Trial - New Path for Post-revascularisation PAD Patients.
    Debus ES; Nehler MR;
    Eur J Vasc Endovasc Surg; 2020 May; 59(5):699-700. PubMed ID: 32307302
    [No Abstract]   [Full Text] [Related]  

  • 58. Peak plasma rivaroxaban levels in patients weighing 120 kg or greater.
    Abdulrehman J; Selby R; Joundi RA; Yeo E
    Thromb Res; 2021 May; 201():15-17. PubMed ID: 33626462
    [No Abstract]   [Full Text] [Related]  

  • 59. [Technical approach to excision of renal cancers with venous thrombus extending to the right auricle. Apropos of 4 cases].
    Jung JL; Bittard M; Belot G; Etievent JP; Gonzalez R
    Ann Urol (Paris); 1985; 19(6):417-9. PubMed ID: 4096519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Left ventricular thrombosis after acute myocardial infarction: relationship with thrombolytic therapy and the patency of the "guilty" vessel].
    Pizzetti G; Belotti G; Chierchia SL
    G Ital Cardiol; 1994 Mar; 24(3):253-60. PubMed ID: 8063060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.